Local regression and control of T1 ‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
ConclusionsExcellent LC could be achieved in T1 ‐2 NPC treated with IMRT. The addition of chemotherapy may offer short‐term response benefit, but no significant LC benefit, so did boost irradiation. Attention should be attached to advanced N stage, the exploration of the recurrence‐related factors, and the necessities of the additional trea tment.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Fen Xue,
Dan Ou,
Chaosu Hu,
Xiayun He Tags: ORIGINAL RESEARCH Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Intensity-Modulated Radiation Therapy | Nasopharyngeal Cancer